Everand Logo

Welcome to Everand!

  • STAT

    Opinion: World leaders have the power to end TB. They must seize the moment

    Ending tuberculosis, the world’s deadliest infectious disease, is doable, but by no means easy.
    by Eric Goosby and Michel Kazatchkine Mar 27, 2018 3 minutes
    Patients infected with multidrug-resistant tuberculosis wait to be seen at the Doctors Without Borders HIV-AIDS clinic in Yangon, Myanmar. Globally in 2016, an estimated 600,000 people developed MDR-TB.

    Attention from global leaders to ending tuberculosis, the world’s deadliest infectious disease, is growing. And that’s very good news. As we mark World TB Day and eagerly await a U.N. meeting on TB in September, we must work to sustain this commitment and build upon it to truly achieve a TB-free world.

    This is doable, but by no means easy. TB claims despite being curable for the vast majority of people who contract it.

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
    Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
    STAT2 min read
    STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
    A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A Boy Dying In Pfizer Trial; AstraZeneca Yanking Covid Shot, And More
    A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.

    Related Books & Audiobooks